148 related articles for article (PubMed ID: 38720953)
21. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
[TBL] [Abstract][Full Text] [Related]
22. Intravenous thrombolysis with recombinant tissue plasminogen activator for ischemic stroke patients over 80 years old: the Fukuoka Stroke Registry.
Matsuo R; Kamouchi M; Fukuda H; Hata J; Wakisaka Y; Kuroda J; Ago T; Kitazono T;
PLoS One; 2014; 9(10):e110444. PubMed ID: 25329379
[TBL] [Abstract][Full Text] [Related]
23. Relationships among hospital acute ischemic stroke volumes, hospital characteristics, and outcomes in the US.
McCarthy L; Daniel D; Santos D; Dhamoon MS
J Stroke Cerebrovasc Dis; 2023 Jul; 32(7):107170. PubMed ID: 37148626
[TBL] [Abstract][Full Text] [Related]
24. Underutilization of Endovascular Therapy in Black Patients With Ischemic Stroke: An Analysis of State and Nationwide Cohorts.
Kim Y; Sharrief A; Kwak MJ; Khose S; Abdelkhaleq R; Salazar-Marioni S; Zhang GQ; Sheth SA
Stroke; 2022 Mar; 53(3):855-863. PubMed ID: 35067099
[TBL] [Abstract][Full Text] [Related]
25. Investigating Outcomes Post-Endovascular Thrombectomy in Acute Stroke Patients With Cancer.
Shapiro SD; Vazquez S; Das A; Dominguez JF; Kamal H; Chong J; Mayer SA; Kaur G; Gandhi C; Al-Mufti F
Neurology; 2022 Dec; 99(23):e2583-e2592. PubMed ID: 36123128
[TBL] [Abstract][Full Text] [Related]
26. Expanded Indication for Recombinant Tissue Plasminogen Activator from 3 to 4.5 h after Onset of Stroke in Japan.
Miyamoto Y; Aso S; Iwagami M; Morita K; Fushimi K; Hamasaki Y; Nangaku M; Doi K; Yasunaga H
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105341. PubMed ID: 33039772
[TBL] [Abstract][Full Text] [Related]
27. [Prospects of thrombolytic therapy for acute ischemic stroke].
Nakashima T; Minematsu K
Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
[TBL] [Abstract][Full Text] [Related]
28. Direct thrombectomy versus bridging thrombolysis with mechanical thrombectomy in middle cerebral artery stroke: a real-world analysis through National Inpatient Sample data.
Kandregula S; Savardekar AR; Sharma P; McLarty J; Kosty J; Trosclair K; Cuellar H; Guthikonda B
Neurosurg Focus; 2021 Jul; 51(1):E4. PubMed ID: 34198246
[TBL] [Abstract][Full Text] [Related]
29. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
30. Machine learning prediction of hospital discharge disposition for inpatients with acute ischemic stroke following mechanical thrombectomy in the United States.
Jabal MS; Wahood W; Ibrahim MK; Kobeissi H; Ghozy S; Kallmes DF; Rabinstein AA; Brinjikji W
J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107489. PubMed ID: 37980845
[TBL] [Abstract][Full Text] [Related]
31. Racial Disparities in Outcomes After THA and TKA Are Substantially Mediated by Socioeconomic Disadvantage Both in Black and White Patients.
Hadad MJ; Rullán-Oliver P; Grits D; Zhang C; Emara AK; Molloy RM; Klika AK; Piuzzi NS
Clin Orthop Relat Res; 2023 Feb; 481(2):254-264. PubMed ID: 36103368
[TBL] [Abstract][Full Text] [Related]
32. Race and income disparity in ischemic stroke care: nationwide inpatient sample database, 2002 to 2008.
Kimball MM; Neal D; Waters MF; Hoh BL
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):17-24. PubMed ID: 22818388
[TBL] [Abstract][Full Text] [Related]
33. Effect of Insurance Status on Outcomes of Acute Ischemic Stroke Patients Receiving Intra-Arterial Treatment: Results from the Paul Coverdell National Acute Stroke Program.
Asaithambi G; Tong X; Lakshminarayan K; Coleman King SM; George MG
J Stroke Cerebrovasc Dis; 2021 May; 30(5):105692. PubMed ID: 33676326
[TBL] [Abstract][Full Text] [Related]
34. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
Shaltoni HM; Albright KC; Gonzales NR; Weir RU; Khaja AM; Sugg RM; Campbell MS; Cacayorin ED; Grotta JC; Noser EA
Stroke; 2007 Jan; 38(1):80-4. PubMed ID: 17122433
[TBL] [Abstract][Full Text] [Related]
35. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.
Broderick JP; Palesch YY; Demchuk AM; Yeatts SD; Khatri P; Hill MD; Jauch EC; Jovin TG; Yan B; Silver FL; von Kummer R; Molina CA; Demaerschalk BM; Budzik R; Clark WM; Zaidat OO; Malisch TW; Goyal M; Schonewille WJ; Mazighi M; Engelter ST; Anderson C; Spilker J; Carrozzella J; Ryckborst KJ; Janis LS; Martin RH; Foster LD; Tomsick TA;
N Engl J Med; 2013 Mar; 368(10):893-903. PubMed ID: 23390923
[TBL] [Abstract][Full Text] [Related]
36. Racial and ethnic disparities in the usage and outcomes of ischemic stroke treatment in the United States.
Metcalf D; Zhang D
J Stroke Cerebrovasc Dis; 2023 Dec; 32(12):107393. PubMed ID: 37797411
[TBL] [Abstract][Full Text] [Related]
37. Endovascular thrombectomy in acute ischemic stroke patients with COVID-19: prevalence, demographics, and outcomes.
de Havenon A; Yaghi S; Mistry EA; Delic A; Hohmann S; Shippey E; Stulberg E; Tirschwell D; Frontera JA; Petersen NH; Anadani M
J Neurointerv Surg; 2020 Nov; 12(11):1045-1048. PubMed ID: 32989032
[TBL] [Abstract][Full Text] [Related]
38. A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke.
Adeoye O; Knight WA; Khoury J; Schmit PA; Sucharew H; Broderick JP; Pancioli AM;
J Stroke Cerebrovasc Dis; 2014; 23(5):e313-5. PubMed ID: 24534128
[TBL] [Abstract][Full Text] [Related]
39. Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non-Vitamin K Antagonist Oral Anticoagulants Before Stroke.
Xian Y; Federspiel JJ; Hernandez AF; Laskowitz DT; Schwamm LH; Bhatt DL; Smith EE; Fonarow GC; Peterson ED
Circulation; 2017 Mar; 135(11):1024-1035. PubMed ID: 28119380
[TBL] [Abstract][Full Text] [Related]
40. Discharge dispositions, complications, and costs of hospitalization in spinal cord tumor surgery: analysis of data from the United States Nationwide Inpatient Sample, 2003-2010.
Sharma M; Sonig A; Ambekar S; Nanda A
J Neurosurg Spine; 2014 Feb; 20(2):125-41. PubMed ID: 24286530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
